Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1990; 16:553-562
© 1990 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bell, M.
Right arrow Articles by Holmes, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bell, M.
Right arrow Articles by Holmes, D., Jr

Percutaneous transluminal angioplasty in patients with multivessel coronary disease: how important is complete revascularization for cardiac event-free survival?

MR Bell, KR Bailey, GS Reeder, AC Lapeyre 3rd, and DR Holmes Jr

Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905.

The relative influences of revascularization status and baseline characteristics on long-term outcome were examined in 867 patients with multivessel coronary disease who had undergone successful coronary angioplasty. These patients represented 83% of a total of 1,039 patients in whom angioplasty had been attempted with an in-hospital mortality and infarction rate of 2.5% and 4.8%, respectively. Emergency coronary bypass surgery was needed in 4.9%. Of the 867 patients, 41% (group 1) were considered to have complete revascularization and 59% (group 2) to have incomplete revascularization. Univariate analysis revealed major differences between these two groups with patients in group 2 characterized by advanced age, more severe angina, a greater likelihood of previous coronary surgery and infarction, more extensive disease and poorer left ventricular function. Over a mean follow-up period of 26 months, the probability of event-free survival was significantly lower for group 2 only with respect to the need for coronary artery surgery (p = 0.004) and occurrence of severe angina (p = 0.04). The difference in mortality was of borderline significance (p = 0.051) and there were no significant differences between groups 1 and 2 in either the incidence of myocardial infarction or the need for repeat angioplasty. Multivariate analysis identified independent baseline predictors of late cardiac events that were then used to adjust the probabilities of event-free survival. This adjustment effectively removed any significant influence of completeness of revascularization on event-free survival for any of the above end points including the combination of death, myocardial infarction and need for coronary artery surgery. Therefore, late outcome in these patients is not significantly influenced by revascularization status but depends more on baseline patient characteristics.


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
G. N. Levine, E. R. Bates, J. C. Blankenship, S. R. Bailey, J. A. Bittl, B. Cercek, C. E. Chambers, S. G. Ellis, R. A. Guyton, S. M. Hollenberg, et al.
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions
J. Am. Coll. Cardiol., December 6, 2011; 58(24): e44 - e122.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, A. M. Hutter Jr, et al.
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol., December 6, 2011; 58(24): e123 - e210.
[Full Text] [PDF]


Home page
CirculationHome page
Writing Committee Members, G. N. Levine, E. R. Bates, J. C. Blankenship, S. R. Bailey, J. A. Bittl, B. Cercek, C. E. Chambers, S. G. Ellis, R. A. Guyton, et al.
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions
Circulation, December 6, 2011; 124(23): e574 - e651.
[Full Text] [PDF]


Home page
CirculationHome page
Writing Committee Members, L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, et al.
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Circulation, December 6, 2011; 124(23): e652 - e735.
[Full Text] [PDF]


Home page
Circ Cardiovasc IntervHome page
C. Wu, A.-M. Dyer, S. B. King III, G. Walford, D. R. Holmes Jr, N. J. Stamato, F. J. Venditti, S. K. Sharma, I. Fergus, A. K. Jacobs, et al.
Impact of Incomplete Revascularization on Long-Term Mortality After Coronary Stenting
Circ Cardiovasc Interv, October 1, 2011; 4(5): 413 - 421.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
E. L. Hannan, C. Wu, G. Walford, D. R. Holmes, R. H. Jones, S. Sharma, and S. B. King III
Incomplete Revascularization in the Era of Drug-Eluting Stents: Impact on Adverse Outcomes
J. Am. Coll. Cardiol. Intv., January 1, 2009; 2(1): 17 - 25.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. L. Hannan, M. Racz, D. R. Holmes, S. B. King III, G. Walford, J. A. Ambrose, S. Sharma, S. Katz, L. T. Clark, and R. H. Jones
Impact of Completeness of Percutaneous Coronary Intervention Revascularization on Long-Term Outcomes in the Stent Era
Circulation, May 23, 2006; 113(20): 2406 - 2412.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. E. Rodriguez, J. Baldi, C. F. Pereira, J. Navia, M. R. Alemparte, A. Delacasa, F. Vigo, D. Vogel, W. O'Neill, I. F. Palacios, et al.
Five-Year Follow-Up of the Argentine Randomized Trial of Coronary Angioplasty With Stenting Versus Coronary Bypass Surgery in Patients With Multiple Vessel Disease (ERACI II)
J. Am. Coll. Cardiol., August 16, 2005; 46(4): 582 - 588.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. J. B. M. van den Brand, B. J. W. M. Rensing, M.-a. M. Morel, D. P. Foley, V. de Valk, A. Breeman, H. Suryapranata, M. M. P. Haalebos, W. Wijns, F. Wellens, et al.
The effect of completeness of revascularization on event-free survival at one year in the arts trial
J. Am. Coll. Cardiol., February 20, 2002; 39(4): 559 - 564.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Kilo, H. Baumer, M. Czerny, M. J. Hiesmayr, M. Ploner, E. Wolner, and M. Grimm
Target vessel revascularization without cardiopulmonary bypass in elderly high-risk patients
Ann. Thorac. Surg., February 1, 2001; 71(2): 537 - 542.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. L. Whitlow, A. P. Dimas, T. M. Bashore, R. M. Califf, M. G. Bourassa, B. R. Chaitman, A. D. Rosen, K. E. Kip, M. L. Stadius, E. L. Alderman, et al.
Relationship of extent of revascularization with angina at one year in the bypass angioplasty revascularization investigation (BARI)
J. Am. Coll. Cardiol., November 15, 1999; 34(6): 1750 - 1759.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. E. Kip, M. G. Bourassa, A. K. Jacobs, L. Schwartz, F. Feit, E. L. Alderman, B. H. Weiner, M. B. Weiss, M. A. Kellett Jr, B. L. Sharaf, et al.
Influence of Pre-PTCA Strategy and Initial PTCA Result in Patients With Multivessel Disease : The Bypass Angioplasty Revascularization Investigation (BARI)
Circulation, August 31, 1999; 100(9): 910 - 917.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. G. Bourassa, K. E. Kip, A. K. Jacobs, R. H. Jones, G. Sopko, A. D. Rosen, B. L. Sharaf, L. Schwartz, B. R. Chaitman, E. L. Alderman, et al.
Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery?: The bypass angioplasty revascularization investigation (BARI)
J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1627 - 1636.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Kornowski, R. Mehran, L. F. Satler, A. D. Pichard, K. M. Kent, A. Greenberg, G. S. Mintz, M. K. Hong, and M. B. Leon
Procedural results and late clinical outcomes following multivessel coronary stenting
J. Am. Coll. Cardiol., February 1, 1999; 33(2): 420 - 426.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
D. Hasdai, A. Lerman, D. E. Grill, C. S. Rihal, and D. R. Holmes Jr.
Medical Therapy after Successful Percutaneous Coronary Revascularization
Ann Intern Med, January 19, 1999; 130(2): 108 - 115.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M. Aristides, M. Gliksman, N. Rajan, and P. Davey
Effectiveness and cost-effectiveness of single bolus treatment with abciximab (Reo Pro) in preventing restenosis following percutaneous transluminal coronary angioplasty in high risk patients
Heart, January 1, 1998; 79(1): 12 - 17.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
X.-Q. Zhao, B. G. Brown, D. K. Stewart, L. A. Hillger, H. X. Barnhart, A. S. Kosinski, W. S. Weintraub, and S. B. King III
Effectiveness of Revascularization in the Emory Angioplasty Versus Surgery Trial : A Randomized Comparison of Coronary Angioplasty With Bypass Surgery
Circulation, June 1, 1996; 93(11): 1954 - 1962.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
N. Wang, S. R. Gundry, G. Van Arsdell, A. J. Razzouk, A. C. Hill, M. Sjolander, K. A. Cavazos, J. M. Brewer, E. E. Vyhmeister, and L. L. Bailey
Percurtaneous transluminal coronary angioplasty failures in patients with multivessel diseaseIs there an increased risk?
J. Thorac. Cardiovasc. Surg., July 1, 1995; 110(1): 214 - 223.
[Abstract] [Full Text]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement